Bringing a new agricultural technology to market is capital intensive, slow, and often too risky for traditional lenders—especially in the early commercialization phase. For Saskatchewan startups working to bridge that gap, the Ag-West Bio Technology Commercialization Investment Fund offers a form of patient, high-impact capital designed specifically for this stage of growth. The fund focuses on early-stage companies in agricultural biotechnology, bioproducts, bioprocessing, natural health products, and functional foods that are moving beyond proof of concept and preparing for market entry.
Rather than a grant, this program provides repayable investment capital, typically ranging from roughly $50,000 to up to $300,000, structured as debt, equity, or a combination of both. What sets this fund apart is its flexibility and long-term approach. Repayment timelines are often measured in years, not months, reflecting the realities of commercializing agri-food innovation. Funding may be released in stages tied to milestones, and the rigorous approval process—while time consuming—can strengthen a company’s business case and help attract additional investors.
Backed by Ag-West Bio and supported by the Government of Saskatchewan, the fund has helped launch and scale notable agri-food innovators over several decades. For founders navigating the “valley of death” between development and revenue, understanding how this investment works could be a critical step in building a viable commercialization strategy.
Was this guide helpful?
Rate it so we can improve our content.
Canada Proactive Disclosure Data
The Canadian government has funded over 400,000 businesses through 1.27 million grants and contributions. Check your eligibility in 60 seconds.